10th Panhellenic Conference of the Hellenic Society of Headache, Athens 15-17 March 2018
November 2, 2023Pharmazac launched the new product Etrozac / etoricoxib.
November 2, 2023Pharmazac launched the new product Quental/quetiapine

Pharmazac launched the new product Quental/quetiapine 50,200,300 and 400mg in prolonged release tablets for the treatment of schizophrenia and bipolar disorders.
Related News
February 12, 2026
November 2, 2023
We are investing in our new pharmaceuticals manufacturing site.
Pharmazac is working on its latest investment a new site of 10.000 sq.m for pharmaceuticals manufacturing, in the industrial zone of Keratea near Athens area . […]
November 2, 2023
Pharmazac launched the new product Zaolin/Vinorelbin
Pharmazac launched the new product Zaolin/Vinorelbin the first generic version for oral use ( soft gelatin caps) in Greece. Zaolin/Vinorelbin is a chemotherapy drug used to […]
November 2, 2023
We are exhibiting and partnering
With Covid-19 on the way of most of our exhibiting activities, Pharmazac has joined in 2020 the largest pharmaceutical partnering events and has participated in more […]
